What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the current subscription status of Clinitech Laboratory Limited IPO?

Clinitech Laboratory Limited IPO has received a total subscription of 34.43 times overall.

IPO GreyPremiumLIVE

Grey Market Intelligence

Clinitech Laboratory Limited

ListedSME

Healthcare · BSE

Clinitech Laboratory Limited, established in 1990, runs 8 diagnostic centers across Thane and Navi Mumbai, offering a wide range of healthcare and diagnostic tests. The company conducts over 3 lakh tests annually in its NABL-accredited labs (National Accreditation Board for Testing and Calibration Laboratories), equipped with advanced technology and high-end equipment. Its Airoli, Navi Mumbai facility holds an ISO 15189:2012 accreditation certificate for quality testing services. As of December 31, 2023, Clinitech has a team of 74 employees dedicated to delivering accurate and reliable healthcare services.

Price Band

₹96

Issue Size

₹5.78 Cr

Lot Size

1200 shares

GMP

₹65

+67.7%

Est. Listing

₹161

at current GMP

Subscribed

34.43x

overall

Open

25 Jul 2024

29 Jul 2024

Allotment

30 Jul 2024

Refund

31 Jul 2024

Demat Credit

1 Aug 2024

Listing

1 Aug 2024

Last updated 12 days ago

Overview Live GMP Subscription Status Allotment Status Filing Documents

Overall Subscription

34.43x

Total Demand

QIB Multiplier

0.00x

Institutions & Funds

NII / HNI

22.37x

High Net-Worth

Retail (RII)

0.00x

Individual Bidders

Category-Wise Subscription Breakup

Live bidding breakdown by institutional, non-institutional, and retail investors

Total 34.43x

Category	Shares Offered	Shares Applied / Bid	Times Subscribed
QIB	285,600	—	0.00x
NIB	285,600	6,390,000	22.37x
RETAIL	—	13,275,600	0.00x
Total	571,200	19,665,600	34.43x

Application-Wise Breakup

Total unique applications received across retail and HNI tranches

Apps 34.03x

Category	Applications Reserved	Applications Received	Times Subscribed
Retail (RII)	176	6,060	34.43x
HNIs (10L +)	1	22	22.37x
HNIs (2-10L)	5	112	22.37x
Total Applications	182	6,194	34.03x

Day-Wise Subscription Progress

Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.

About Clinitech Laboratory Limited Public Issue & Market Profile

Clinitech Laboratory Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹5.78 Crores. The shares are offered at a price band of ₹96 to ₹96 per equity share on BSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.

Bidding & Quota Instructions:

The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.

Allotment Reconciliation Schedule:

Following the close of bidding on 2024-07-29, the basis of allotment is scheduled to be finalized on 2024-07-30. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Bigshare Services Private Limited) or the BSE allotment checking window.

Frequently Asked Questions

What is Clinitech Laboratory Limited IPO GMP today?

The latest Grey Market Premium (GMP) for Clinitech Laboratory Limited IPO is ₹65 per equity share. Based on the upper price band of ₹96 to ₹96 per equity share, the estimated listing price is ₹161 (+67.7% expected listing gain).

What is the expected profit per lot for Clinitech Laboratory Limited IPO?

With a lot size of 1200 shares and current GMP of ₹65, the expected profit per application lot is approx ₹78,000 (+67.7% gain). Minimum application cost is approx ₹1,15,200.

What is the issue size and price band for Clinitech Laboratory Limited IPO?

The Clinitech Laboratory Limited IPO aggregate issue size is ₹5.78 Crores with an equity price band set at ₹96 to ₹96 per equity share. The retail lot size is 1200 shares requiring a minimum capital outlay of approx. ₹1,15,200.

How can I check Clinitech Laboratory Limited IPO live subscription demand?

Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 34.43x (Retail: 0.00x, QIB: 0.00x, NII: 22.37x). You can track live multiples directly on our dedicated subscription page.

Where and when will Clinitech Laboratory Limited IPO allotment status be published?

The basis of allotment will be published on the official registrar portal (Bigshare Services Private Limited) and the BSE status verification website on or around 2024-07-30. Investors can verify status using PAN card or application number.

When is the listing date for Clinitech Laboratory Limited IPO?

Clinitech Laboratory Limited shares are scheduled to list on BSE on 2024-08-01.